DOCK8 and hyperinsulinemic hypoglycemia, familial, 4: The patient benefited from a combined treatment of siltuximab, an IL-6 inhibitor, and prednisone, suggesting that targeting IL-6 with therapies like siltuximab could effectively manage severe infections in patients with DOCK8 deficiency [119].